Superficially does seem like Pfizer’s new drug is superior. ”Only about 0.8% of patients who received Paxlovid were hospitalized through day 28 compared to 7% of patients who received placebo and were hospitalized or died.Merck reported that 7.3% of patients who received molnupiravir were either hospitalized or died through day 29 compared with 14.1% of placebo-treated patients.”Looking at the above figures, about double of those who received placebo for Merck’s died compared to Pfizer. Does it mean that the patients recruited into Merck’s study are sicker? Without going into studying both trials in detail, suffice to say both appear to be efficacious but I’m not too sure if Pfizer’s is superior to Merck’s.
Will Pfizer Outgun Merck With Oral COVID-19 Pill?<blockquote>辉瑞口服新冠肺炎药丸会超过默克吗?</blockquote>
Wow! More spending and hopefully will drivestock prices higher which will make the rich richer? A quick glance at the kind of social spending and it seems it is even more socialist than some countries? Hmmm…
House passes $1.75 trillion Biden plan that funds universal pre-K, Medicare expansion and renewable energy credits<blockquote>众议院通过1.75万亿美元的拜登计划,为全民学前教育、医疗保险扩张和可再生能源信贷提供资金</blockquote>